Sarepta Therapeutics
SRPT
#1592
Rank
ยฃ8.67 B
Marketcap
ยฃ90.77
Share price
3.38%
Change (1 day)
37.28%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

Sarepta Therapeutics (SRPT) - Total assets

Total assets on the balance sheet as of September 2024 : ยฃ2.86 Billion

According to Sarepta Therapeutics 's latest financial reports the company's total assets are ยฃ2.86 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Sarepta Therapeutics - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2023-12-31ยฃ2.56 B-0.9%
2022-12-31ยฃ2.58 B10.88%
2021-12-31ยฃ2.33 B6.5%
2020-12-31ยฃ2.18 B57.52%
2019-12-31ยฃ1.39 B7.46%
2018-12-31ยฃ1.29 B33.67%
2017-12-31ยฃ0.96 B181.57%
2016-12-31ยฃ0.34 B86.04%
2015-12-31ยฃ0.18 B-2.51%
2014-12-31ยฃ0.18 B7.21%
2013-12-31ยฃ0.17 B39.37%
2012-12-31ยฃ0.12 B262.58%
2011-12-31ยฃ34.97 M17.45%
2010-12-31ยฃ29.78 M-19.71%
2009-12-31ยฃ37.09 M112.9%
2008-12-31ยฃ17.42 M-10.42%
2007-12-31ยฃ19.44 M-6.77%
2006-12-31ยฃ20.86 M-36.22%
2005-12-31ยฃ32.71 M120.2%
2004-12-31ยฃ14.85 M-43.64%
2003-12-31ยฃ26.35 M47.74%
2002-12-31ยฃ17.83 M-23.51%
2001-12-31ยฃ23.32 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
ยฃ42.57 B 1,388.33%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.44 B-49.48%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.07 B-62.57%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.39 B-86.35%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ3.34 B 16.81%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.46 B-48.83%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.63 B-42.97%๐Ÿ‡บ๐Ÿ‡ธ USA